MedTrace Logo

Study of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690

NCT00937781 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 307

Last updated 2017-05-17

No results posted yet for this study

Summary

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment.

PURPOSE: This research study is looking at tumor tissue samples from patients with melanoma treated on clinical trial EST-1690.

Conditions

  • Melanoma (Skin)

Interventions

GENETIC

RNA analysis

GENETIC

gene expression analysis

GENETIC

microarray analysis

GENETIC

polymerase chain reaction

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • ECOG-ACRIN Cancer Research Group

    lead NETWORK

Principal Investigators

  • Mohammed Kashani-Sabet, MD · University of California, San Francisco

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-08
Primary Completion
2011-08-08
Completion
2011-08-08

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00937781 on ClinicalTrials.gov